JAK1 and hepatocellular carcinoma: To further evaluate the clinical value of p-ACAP4Y843 in HCC, we performed HE and immunohistochemical staining of HCC tumor tissues and adjacent tissues using antibodies against ACAP4, p-ACAP4Y843, JAK1, and p-JAK1 (Figure 6I-6K).